IBTR! 2.0: 10-year Ipsilateral Breast Tumor Recurrence (without RT) - Evidencio
IBTR! 2.0: 10-year Ipsilateral Breast Tumor Recurrence (without RT)
The Ipsilateral Breast Tumor Recurrence (IBTR) 2.0 is designed for use by physicians to guide medical decision-making regarding the use of radiation therapy in breast cancer patients who have undergone breast conserving surgery and appropriate axillary evaluation. This model calculates an evidence-based estimate of the 10-year ipsilateral breast tumor recurrence risk with and without the addition of whole breast radiation therapy. 

The IBTR 2.0 is not intended for use in the post-mastectomy setting, and it is not meant to address patients with multicentric disease or with in-situ only disease. It is assumed that all pathological specimens have been microscopically assessed with current histopathological standards. It is presumed that patients who are lymph node positive (with the exception of micrometastatic lymph node disease) will receive systemic therapy, either chemotherapy or hormonal therapy. The calculated benefit of hormonal therapy in this model is based on the tamoxifen literature and has been extrapolated to the use of aromatase inhibitors. Recent studies indicate that aromatase inhibitors have a similar, and possibly a slightly superior, impact on local control. 
Les auteurs de la recherche: Mona Sanghani, Pauline T. Truong, Rita Abi Raad, Andrzej Niemierko, Mary Lesperance, Ivo A. Olivotto, David E. Wazer, Alphonse G. Taghian
Version: 1.3
  • Public
  • Oncologie
  • {{ modelType }}
  • Détails
  • Valider le algorithme
  • Sauvegarder l'entrée
  • Entrée de la charge
Affichage
Unités

{{ section.title }}

{{ section.description }}

Calculer le résultat

Définir d'autres paramètres pour effectuer le calcul

10-Year risk of ipsilateral breast tumor recurrence without radiation therapy is: %

{{ resultSubheader }}
{{ $t('download_result_availability') }}
{{ chart.title }}
Intervalle de résultats {{ additionalResult.min }} à {{ additionalResult.max }}

Informations conditionnelles

The arm of the IBTR! nomogram that calculates local recurrence risk with radiation has undergone rigorous validation testing with collaboration of two large institutional datasets. The calculation of local recurrence risk without radiation has not been validated because of unavailability of a large diverse cohort of patients that did not receive radiation therapy. Therefore the predicted recurrence risk without radiation therapy is based on the consistent relative risk reduction of 0.7 seen across multiple randomized trials with the use of breast irradiation.

{{ file.classification }}
PRO
Note
Les notes ne sont visibles que dans le téléchargement des résultats et ne sont pas sauvegardées par Evidencio.

Ce algorithme est fourni à des fins d'éducation, de formation et d'information. Il ne doit pas être utilisé pour aider à la prise de décision médicale ou pour fournir des services médicaux ou de diagnostic. Lire l'intégralité de notre disclaimer.

Algorithmes sous-jacents Une partie de
Commentaires
Commentaire
Veuillez saisir un commentaire
Les commentaires sont visibles par tous

Retour d'information sur le algorithme

Pas encore de retour d'information 1 Commentaire {{ model.comments.length }} Commentaires
Sur {{ comment.created_at }} {{ comment.user.username }} un auteur qui n'est plus enregistré a écrit :
{{ comment.content }}
logo

Veuillez vous connecter pour activer les fonctions d'impression d'Evidencio

Pour utiliser les fonctions d'impression d'Evidencio, vous devez être connecté.
Si vous n'avez pas de compte communautaire Evidencio, vous pouvez créer un compte personnel gratuit à:

https://www.evidencio.com/registration

Résultats imprimés - Exemples {{ new Date().toLocaleString() }}


Avantages du compte communautaire Evidencio


With an Evidencio Community account you can:

  • Create and publish your own prediction algorithms.
  • Share your prediction algorithms with your colleagues, research group, organization or the world.
  • Review and provide feedback on algorithms that have been shared with you.
  • Validate your algorithms and validate algorithms from other users.
  • Find algorithms based on Title, Keyword, Author, Institute, or MeSH classification.
  • Use and save prediction algorithms and their data.
  • Use patient specific protocols and guidelines based on sequential algorithms and decision trees.
  • Stay up-to-date with new algorithms in your field as they are published.
  • Create your own lists of favorite algorithms and topics.

A personal Evidencio account is free, with no strings attached!
Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction algorithms.


Clause de non-responsabilité : les calculs ne doivent jamais dicter les soins aux patients et ne remplacent pas le jugement d'un professionnel.
Evidencio v3.38 © 2015 - 2025 Evidencio. Tous droits réservés